Consequently, the reduced mRNA expression of fibrogenic genes (Col1a1 and TGFβ1) and collagen deposition observed in the SPA-deficient mice suggests that SPA promotes stellate cell synthetic phenotype in MASLD. The gene discussed is SFTPA1; the disease is metabolic dysfunction-associated steatotic liver disease.